Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin

Glycylglutamine API Manufacturers & Suppliers

1 verified results
Get full market intelligence report
Get full market intelligence report
Full access. Full negotiation power All Glycylglutamine data. Full access. Full negotiation power

Commercial-scale Suppliers

Producer
Produced in  China
|

Employees: 450+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
CoA

All certificates

GMP
MSDS
BSE/TSE
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Glycylglutamine data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Glycylglutamine | CAS No: 13115-71-4 | GMP-certified suppliers

A medication that serves as an experimental dipeptide with potential applications in neural inhibition and peptide research within amino acid and protein therapeutic classes.

Therapeutic categories

Amino Acids, Peptides, and ProteinsNeural InhibitionOligopeptidesPeptides
Generic name
Glycylglutamine
Molecule type
small molecule
CAS number
13115-71-4
DrugBank ID
DB15990
Approval status
Experimental drug

Product Snapshot

  • Glycylglutamine is available in injectable formulations including solution and emulsion suitable for intravenous and parenteral administration
  • It is primarily investigated for applications related to cellular metabolism and nutritional support
  • Currently, Glycylglutamine holds an experimental status with no approved regulatory market authorizations

Clinical Overview

Glycylglutamine (CAS Number 13115-71-4) is a dipeptide composed of glycine and glutamine amino acid residues. It is classified within the categories of amino acids, peptides, and proteins, with additional relevance to neural inhibition and oligopeptides. Currently, glycylglutamine is categorized as an experimental compound, and there are no approved clinical indications or established pharmacodynamic profiles associated with this molecule.

The mechanism of action for glycylglutamine has not been definitively characterized in available scientific literature or regulatory sources. As such, its functional pharmacological effects remain to be fully elucidated. Similarly, key absorption, distribution, metabolism, and excretion (ADME) properties are not well documented, which limits a comprehensive understanding of its metabolic pathways and potential bioavailability.

Safety and toxicity data for glycylglutamine are minimal or absent, reflecting its experimental status. There are no widely recognized adverse effect profiles or contraindications reported. Consequently, the clinical safety of glycylglutamine is undetermined, implying that it should be approached with caution in any investigational or research context.

No pharmaceutical brands or marketed products containing glycylglutamine are currently available. Its usage is primarily confined to experimental research, potentially exploring peptide function or neural inhibition pathways.

From an API sourcing and procurement perspective, quality control of glycylglutamine must adhere to rigorous analytical standards to ensure purity, identity, and consistency, particularly given its experimental nature. Suppliers should provide comprehensive certificates of analysis, including data on peptide content and absence of contaminants, to support research reliability and regulatory compliance in investigational applications.

Identification & chemistry

Generic name Glycylglutamine
Molecule type Small molecule
CAS 13115-71-4
UNII H7125Z98HT
DrugBank ID DB15990

Formulation & handling

  • Glycylglutamine is a small molecule with high water solubility, suitable for intravenous and parenteral formulations.
  • Its negative LogP value indicates low lipophilicity, favoring aqueous-based injectable formulations such as solutions and emulsions.
  • Formulations should ensure sterility and stability given its experimental status and parenteral administration routes.

Regulatory status

Glycylglutamine is a type of Other substances


The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.

Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.

Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.

Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.

In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.

Glycylglutamine API manufacturers & distributors

Compare qualified Glycylglutamine API suppliers worldwide. We currently have 1 companies offering Glycylglutamine API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Producer
China China BSE/TSE, CoA, GMP, MSDS15 products

When sending a request, specify which Glycylglutamine API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Glycylglutamine API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.